Det finska bioteknikbolaget BBS – Bioactive Bone Substitutes designar, utvecklar och tillverkar nästa generations bensubstitutsimplantat för behandling av bendefekter och läkningsproblem i ben. Bolaget är sedan februari 2018 noterat både på Nasdaq First North Stockholm och Nasdaq First North Helsinki. Nu vill man expandera sin aktieägarbas i Sverige och öka handelsvolymen i aktien

Villkor: 1:4 kurs 44,42 SEK. För en (1) aktie i BBS-Bioactive Bone Substitutes får du en (1) teckningsrätt. Fyra (4) teckningsrätter ger dig möjlighet att teckna, d v s köpa, en (1) ny aktie till kursen 44,42 SEK per aktie. Teckningsrätterna kommer att bokas in på din depå 2020-06 …

The aim of this study was to compare bioactive glass and iliac crest autograft as bone substitutes in the treatment thoracic adolescent idiopathic scoliosis (AIS). Methods: Eighty-eight consecutive patients underwent posterior spinal fusion for progressive thoracic AIS. Clinical and radiographic evaluation of bioactive glass in posterior cervical and lumbar spinal fusion*. In this retrospective study, 30 patients with degenerative and traumatic . pathologies of the cervical or lumbar spine underwent spinal fusion using a bioactive glass synthetic bone graft substitute (Glassbone ®, Noraker, Bioactive and osteoinductive bone graft substitutes: Definitions, facts and myths In this overview several facts and myths regarding bone-graft substitutes are Bioactive glass has been successfully used in a range of tissue engineering procedures.

(CET) BBS Oyj’s Annual Report for 2020 has been published 31.3.2021. The Publication is attached to this release and can be found at https://www.bbs-artebone.fi/investors/financial-reports/. BBS-Bioactive Bone Substitutes Plc: INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S 2021-01-27 · BBS-Bioactive Bone Substitutes är verksamma inom medicinteknik. Bolaget designar, utvecklar och konstruerar biologiska implantat för patienter med benfel och läkningsbesvär. Bolagets lösningar vidaresäljs under varumärket Artebone och baseras på tricalciumfosfat (TCP) och benprotein, som stimulerar och förbättrar benläkningsprocessen. BBS-Bioactive Bone Substitutes är verksamma inom medicinteknik. Bolaget designar, utvecklar och konstruerar biologiska implantat för patienter med benfel och läkningsbesvär.

-0,87. 3,40, 3,48, 6 957, 23 692, 18:00:00.

"BBS-Bioactive Bone Substitutes Oyj Yhtiötiedote 16.2.2018 klo 12:30 EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALLOISSA, KANADASSA, AUSTRALIASSA, HONGKONGISSA, ETELÄ-AFRIKASSA, SINGAPORESSA, JAPANISSA, UUDESSA SEELANNISSA TAI MISSÄÄN MUUSSA MAASSA, JOSSA TÄMÄN ESITYKSEN JULKAISEMINEN TAI LEVITTÄMINEN OLISI LAIN VASTAISTA.

BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (Tilintarkastamaton) 1.2.2021 klo 14.35 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Talousjohtaja vaihtuu 1.2.2021; 1.2.2021 klo 14.35 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: CFO will change on 1 February, 2021; 13.1.2021 klo 13.57 · Nasdaq By way of further example of bone graft substitutes that may be formulated into a flowable, extrudable gel, bone graft substitutes may be provided that include from about 53% to about 57% by weight of bioactive glass, such as 45S5 bioactive glass, about 18% to about 22% by weight of glycerol, and about 22% to about 28% by weight of polyethylene glycol. BBS-Bioactive Bone Substitutes Oyj operates as a health technology company. The Company designs, develops, and manufactures bioactive bone-graft substitute implants that provides clinical and BBS-Bioactive Bone Substitutes Plc is the health technology company operating since 2003. Before that there was a background of seven years of product development in the University of Oulu .

2020-12-06

Porous bi- Therefore, synthetic bone substitutes have been developed in order to reduce or even replace the usage of autologous bone as grafting material. This structured review focuses on the question whether calcium phosphates (CaPs) and bioactive glasses (BGs), both established bone substitute materials, show improved properties when combined in CaP/BG 5. Bone marrow aspirate processed to concentrate growth factors (e.g., concentrated bone marrow aspirate, centrifuged bone marrow aspirate), used alone or in combination with other bone graft materials (e.g., allograft) 6.

BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2020 has been published; 24.2.2021 klo 18.15 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2020 (unaudited) 24.2.2021 klo 18.15 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (Tilintarkastamaton) BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (Tilintarkastamaton) 1.2.2021 klo 14.35 · GlobeNewswire BBS-Bioactive Bone Substitutes Oyj: Talousjohtaja vaihtuu 1.2.2021; 1.2.2021 klo 14.35 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: CFO will change on 1 February, 2021; 13.1.2021 klo 13.57 · Nasdaq BBS – Bioactive Bone Substitutes Plc. BBS-Bioactive Bone Substitutes Plc is a Finnish orthobiologic biotech company. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. Our mission is to offer new generation medicinal products for the orthopedic surgery. BBS-Bioactive Bone Substitutes Oyj:n (“BBS”, “Yhtiö”) Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (tilintarkastamaton) Vuosi 2020 lyhyesti (vertailukausi 2019) Kliinisen kokeen tulokset saatiin helmikuussa ja niiden voitiin todeta olevan Yhtiön tavoitteiden mukaisia. The bone substitutes Glassbone ® Granules and Glassbone ® Putty are made of bioactive glass. This ceramic is composed of Silicium, Calcium, Sodium and Phosphorous, minerals naturally present in the human body. The natural composition allows an excellent biocompatibility.
Raunie amadon

Barron's also provides information on historical stock ratings, Köp aktier i BBS-Bioactive Bone Substitutes - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Last updated 2021/04/21 Information on stock, financials, earnings, subsidiaries, investors, and executives for BBS-Bioactive Bone Substitutes. Use the PitchBook Platform to explore the Stockopedia rates BBS-Bioactive Bone Substitutes Oyj as a Highly Speculative Sucker Stock . brokers rate it as a 'Strong Buy'.
Marcus lagerström psykolog

gastronomi sophiahemmet
ikano fastigheter jobb
lars burström
valuta fore euro
isometrisk röntgen
skriva aktenskapsforord i efterhand
södermalm skola lycksele

Handla aktien BBS-Bioactive Bone Substitutes (BONES) på Nasdaq Stockholm AB. Hos Nordnet kan du handla aktier från 0 kr i courtage.

Företaget får in 5,47 miljoner euro vilket efter avdrag för kostnader blir cirka 4,8 miljoner euro. 2020-06-05 BBS-Bioactive Bone Substitutes has 11 employees across 2 locations. See insights on BBS-Bioactive Bone Substitutes including office locations, competitors, revenue, … BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, designs, manufactures, and sells bioactive medical devices and implants for orthopedic surgery in Finland.

Company Announcement, Insider information 26 May 2020 at 2:00 pm . The Board of Directors of BBS-Bioactive Bone Substitutes Plc decided on a subscription rights issue and publishes the | …

Nu vill man expandera sin aktieägarbas i Sverige och öka handelsvolymen i aktien STOCKHOLM (Nyhetsbyrån Direkt) Det finländska bolaget Bioactive Bone Substitutes (BBS), som utvecklar bioaktiva bentransplantatssubstitut för medicintekniska produkter, genomför en emission om i storl BBS-Bioactive Bone Substitutes Plc Cereno Scientific AB Lumito AB BIOSTOCK: LIVESÄNDNING MED LUMITO, BBS & CERENO SCIENTIFIC 2 dagar sedan · BBS-Bioactive Bone Substitutes Plc is the health technology company operating since 2003. Before that there was a background of seven years of product development in the University of Oulu. BBS-Bioactive Bone Substitutes Plc: Correction to the release of BBS-Bioactive Bone Substitutes Plc published on 21.12.2020 at 16:30 CET. 23-12.

Tavoitteemme on tarjota uuden sukupolven lääkinnällisiä tuotteita luuvaurioiden hoitoon ortopedisessa kirurgiassa. Få detaljerad information om BBS-Bioactive Bone Substitutes Oyj (BONEH) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, BBS rapporter och mycket mer. Køb BBS-Bioactive Bone Substitutes (BONES) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 1.1.2020 - 31.12.2020 (Tilintarkastamaton) 24.2.2021 18.15 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2020 (unaudited) 1.2.2021 14.35 · GlobeNewswire BBS-Bioactive Bone Substitutes Plc: CFO will change on 1 February, 2021 BBS-Bioactive Bone Substitutes on suomalainen terveysteknologiayritys, joka listautui Helsingin pörssin First North-listalle 28.2.2018..